First Time Loading...

Revolution Medicines Inc
NASDAQ:RVMD

Watchlist Manager
Revolution Medicines Inc Logo
Revolution Medicines Inc
NASDAQ:RVMD
Watchlist
Price: 35.96 USD 1.78% Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

RVMD Price Targets Summary
Revolution Medicines Inc

Wall Street analysts forecast RVMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RVMD is 41.65 USD with a low forecast of 34.34 USD and a high forecast of 50.4 USD.

RVMD Lowest Forecast
Wall Street Target
34.34 USD
5% Downside
RVMD Average Forecast
Wall Street Target
41.65 USD
16% Upside
RVMD Highest Forecast
Wall Street Target
50.4 USD
40% Upside
Lowest
Price Target
34.34 USD
5% Downside
Average
Price Target
41.65 USD
16% Upside
Highest
Price Target
50.4 USD
40% Upside

RVMD Last Price Targets
Revolution Medicines Inc

The latest public price target was made on Apr 19, 2024 by Ben Burnett from Stifel Nicolaus , who expects RVMD stock to rise by 20% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Ben Burnett
Stifel Nicolaus
43 USD
Upside 20%
1 week ago
Apr 19, 2024
Revolution (RVMD) PT Raised to $43 at Stifel
StreetInsider
Jay Olson
Oppenheimer
45 USD
Upside 25%
2 weeks ago
Apr 12, 2024
Revolution (RVMD) PT Raised to $45 at Oppenheimer, 'readouts should drive additional upside'
StreetInsider
Ami Fadia
Needham
46 USD
Upside 28%
2 weeks ago
Apr 12, 2024
Revolution (RVMD) PT Raised to $46 at Needham
StreetInsider
Laura Prendergast
Raymond James
48 USD
Upside 33%
2 weeks ago
Apr 10, 2024
Raymond James Upgrades Revolution (RVMD) to Strong Buy
StreetInsider
Dane Leone
Raymond James
30 USD
Downside 17%
5 months ago
Nov 16, 2023
Cancer Player Revolution Medicines Gets Bullish Rating: Here's Details
Benzinga
Ben Burnett
Stifel Nicolaus
Price Target 43 USD
Upside/Downside 20%
View Source
Jay Olson
Oppenheimer
Price Target 45 USD
Upside/Downside 25%
View Source
Ami Fadia
Needham
Price Target 46 USD
Upside/Downside 28%
View Source
Laura Prendergast
Raymond James
Price Target 48 USD
Upside/Downside 33%
View Source
Dane Leone
Raymond James
Price Target 30 USD
Upside/Downside 17%
View Source
Revolution Medicines Inc Competitors:
Price Targets
4587
PeptiDream Inc
68% Upside
KRRO
Korro Bio Inc
111% Upside
GTH
Genetron Holdings Ltd
67% Downside
M
MLYS
Mineralys Therapeutics Inc
183% Upside
4587
PeptiDream Inc
68% Upside
KRRO
Korro Bio Inc
111% Upside
GTH
Genetron Holdings Ltd
67% Downside
M
MLYS
Mineralys Therapeutics Inc
183% Upside
ASND
Ascendis Pharma A/S
35% Upside
MOR
MorphoSys AG
14% Downside
KRON
Kronos Bio Inc
334% Upside
BVXP
Bioventix PLC
36% Upside

Revenue
Forecast

Revenue Estimate
Revolution Medicines Inc

For the last 5 years the compound annual growth rate for Revolution Medicines Inc's revenue is -11%. The projected CAGR for the next 3 years is 23%.

-11%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Revolution Medicines Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Revolution Medicines Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-56%
Average Miss
What are analyst estimates?

See Also

Summary
RVMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
RVMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RVMD stock valuation using valuation multiples.
Wall Street Estimates
RVMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RVMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RVMD's stock price target?
Price Target
41.65 USD

According to Wall Street analysts, the average 1-year price target for RVMD is 41.65 USD with a low forecast of 34.34 USD and a high forecast of 50.4 USD.

What is Revolution Medicines Inc's Revenue forecast?
Projected CAGR
23%

For the last 5 years the compound annual growth rate for Revolution Medicines Inc's revenue is -11%. The projected CAGR for the next 3 years is 23%.

ALPHA SPREAD
Join more than 132,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.